Existing and prospective investors
Reporting questions, account servicing, documentation, and eligibility.
[email protected]
Investor relations
Clear reporting, consistently delivered.
Our aim is that investors can read our reporting and understand what they own, how it performed, and what we are watching.
How we communicate
Reporting written to be understood.
Investor communication is a core responsibility, not an administrative task. Our aim is that an investor can read our reporting and understand what they own, how it performed, what changed, and what we are watching — without needing to decode it.
That means stating unfavorable developments as plainly as favorable ones, explaining valuation methodology, and being explicit about the assumptions behind any figure that depends on judgment.
Typical reporting
What investors receive
- Periodic statements covering position-level detail and activity
- Portfolio commentary on operations, capital projects, and asset developments
- Valuation summaries with methodology and material assumptions described
- Market perspective relevant to the asset classes held
- Tax reporting materials in accordance with applicable requirements
- Annual reporting summarizing the year and the outlook
Specific reporting packages, frequency, and content vary by investment structure and are governed by the applicable offering and subscription documents.
Everything else
Questions about the firm, our philosophy, and the assets we follow.
[email protected]Reports and resources
Annual reporting archive and investor reference material.
View annual reports →Prime Summa is a privately held firm. This page is provided for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy any security.
Any offering is made solely through formal offering documents, which contain complete information regarding terms, fees, conflicts of interest, and risk factors, and only to persons who meet applicable eligibility requirements. Past performance is not indicative of future results.